NeuroSolv Therapeutics Developing New Therapy to Treat Spinal Cord Injury, Partners With AscellaHealth to Bring Therapy to Market

DUBLIN--(BUSINESS WIRE)--In partnership with AscellaHealth, NeuroSolv Therapeutics is seeking to expand the clinical trial development programme and accelerate regulatory approval procedures to optimise the prospect of bringing Perineline™ to market.

To read more, click here.

Cookie Policy

Read our Privacy Policy to learn more.